British Airways Pensions Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-52,815
Closed -$14.5M 103
2018
Q1
$14.5M Sell
52,815
-3,019
-5% -$937K 0.51% 59
2017
Q4
$17.8M Sell
55,834
-23,016
-29% -$7.38M 0.56% 50
2017
Q3
$24.7M Buy
78,850
+45,476
+136% +$13.5M 0.75% 62
2017
Q2
$9.05M Sell
33,374
-86,675
-72% -$22.9M 0.26% 103
2017
Q1
$32.8M Buy
120,049
+6,689
+6% +$1.89M 0.99% 43
2016
Q4
$32.2M Buy
113,360
+24,063
+27% +$7.13M 0.93% 52
2016
Q3
$27.9M Buy
+89,297
New +$26.4M 0.82% 58
2015
Q2
Sell
-39,322
Closed -$16.6M 125
2015
Q1
$16.6M Hold
39,322
0.51% 94
2014
Q4
$13.3M Buy
+39,322
New +$12.7M 0.44% 89

Other funds holding BIIB

British Airways Pensions Investment Management's BIIB Position: Q2 2018 in Review

British Airways Pensions Investment Management sold out of Biogen (BIIB) in Q2 2018, closing a stake of 52,815 shares — an estimated $14.5M sold.

British Airways Pensions Investment Management first reported a position in BIIB in Q4 2014 and held it in 9 quarters. The position peaked at $32.8M in Q1 2017. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • British Airways Pensions Investment Management reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • British Airways Pensions Investment Management sold 52,815 Biogen shares in Q2 2018, an estimated $14.5M.
  • British Airways Pensions Investment Management first reported a position in Biogen in Q4 2014 and held it in 9 quarters.
  • British Airways Pensions Investment Management's Biogen position peaked at $32.8M in Q1 2017.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on British Airways Pensions Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.